Histogen (HSTO) Competitors $0.21 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrends HSTO vs. ADTX, CHRO, VRPX, INM, NBY, GRTS, SBFM, BNOX, PTPI, and THARShould you be buying Histogen stock or one of its competitors? The main competitors of Histogen include Aditxt (ADTX), Chromocell Therapeutics (CHRO), Virpax Pharmaceuticals (VRPX), InMed Pharmaceuticals (INM), NovaBay Pharmaceuticals (NBY), Gritstone bio (GRTS), Sunshine Biopharma (SBFM), Bionomics (BNOX), Petros Pharmaceuticals (PTPI), and Tharimmune (THAR). These companies are all part of the "pharmaceutical products" industry. Histogen vs. Aditxt Chromocell Therapeutics Virpax Pharmaceuticals InMed Pharmaceuticals NovaBay Pharmaceuticals Gritstone bio Sunshine Biopharma Bionomics Petros Pharmaceuticals Tharimmune Histogen (NASDAQ:HSTO) and Aditxt (NASDAQ:ADTX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations, institutional ownership and risk. Which has better valuation & earnings, HSTO or ADTX? Histogen has higher earnings, but lower revenue than Aditxt. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHistogen$19K47.78-$10.62M-$2.81-0.08Aditxt$640K3.18-$32.38MN/AN/A Does the MarketBeat Community believe in HSTO or ADTX? Histogen received 3 more outperform votes than Aditxt when rated by MarketBeat users. Likewise, 58.33% of users gave Histogen an outperform vote while only 44.44% of users gave Aditxt an outperform vote. CompanyUnderperformOutperformHistogenOutperform Votes758.33% Underperform Votes541.67% AditxtOutperform Votes444.44% Underperform Votes555.56% Is HSTO or ADTX more profitable? Histogen's return on equity of 0.00% beat Aditxt's return on equity.Company Net Margins Return on Equity Return on Assets HistogenN/A N/A N/A Aditxt N/A -615.43%-157.59% Which has more volatility and risk, HSTO or ADTX? Histogen has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Aditxt has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Do insiders and institutionals have more ownership in HSTO or ADTX? 15.5% of Aditxt shares are held by institutional investors. 3.3% of Histogen shares are held by insiders. Comparatively, 1.7% of Aditxt shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer HSTO or ADTX? In the previous week, Aditxt had 1 more articles in the media than Histogen. MarketBeat recorded 1 mentions for Aditxt and 0 mentions for Histogen. Histogen's average media sentiment score of 0.00 equaled Aditxt'saverage media sentiment score. Company Overall Sentiment Histogen Neutral Aditxt Neutral Do analysts recommend HSTO or ADTX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Histogen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAditxt 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryHistogen beats Aditxt on 7 of the 11 factors compared between the two stocks. Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Get Histogen News Delivered to You Automatically Sign up to receive the latest news and ratings for HSTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSTO vs. The Competition Export to ExcelMetricHistogenPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$908,000.00$6.74B$5.02B$8.43BDividend YieldN/A7.94%7.52%4.16%P/E Ratio-0.0811.77128.7716.66Price / Sales47.78291.011,724.9679.31Price / CashN/A46.0936.9133.53Price / Book0.075.304.605.19Net Income-$10.62M$150.82M$114.09M$223.67M7 Day Performance-29.17%-0.82%110.41%2.70%1 Month Performance-2.30%15.17%124.29%8.76%1 Year Performance-35.61%36.66%154.67%28.76% Histogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSTOHistogenN/A$0.21flatN/A-35.6%$897,000.00$19,000.00-0.077ADTXAditxt0.1501 of 5 stars$0.53-5.4%N/A-99.8%$2.24M$329,739.000.0047Gap DownHigh Trading VolumeCHROChromocell TherapeuticsN/A$0.64+3.2%N/AN/A$3.58MN/A0.004VRPXVirpax Pharmaceuticals1.1339 of 5 stars$0.73-1.4%$3.00+312.7%-89.9%$3.55MN/A0.007Gap UpINMInMed Pharmaceuticals0.4163 of 5 stars$0.26-3.7%N/A-43.5%$3.55M$4.60M-0.2013NBYNovaBay PharmaceuticalsN/A$0.75+4.2%N/A-94.0%$3.50M$14.73M-0.0130Analyst ForecastGap UpGRTSGritstone bio1.6356 of 5 starsN/A$2.17+∞N/A$3.50M$496,000.00-0.03190Gap DownHigh Trading VolumeSBFMSunshine Biopharma1.0551 of 5 stars$2.84+0.7%N/A-90.2%$3.47M$24.09M-0.013Upcoming EarningsBNOXBionomics2.1579 of 5 stars$0.20flat$8.00+3,963.0%-92.2%$3.45M$10,000.000.00N/ANews CoveragePTPIPetros Pharmaceuticals3.2653 of 5 stars$0.34-8.1%$4.00+1,077.5%-75.9%$3.40M$4.12M-0.0520THARTharimmune1.8622 of 5 stars$2.69-5.6%N/A-95.5%$3.27MN/A0.002Upcoming EarningsGap Down Related Companies and Tools Related Companies Aditxt Competitors Chromocell Therapeutics Competitors Virpax Pharmaceuticals Competitors InMed Pharmaceuticals Competitors NovaBay Pharmaceuticals Competitors Gritstone bio Competitors Sunshine Biopharma Competitors Bionomics Competitors Petros Pharmaceuticals Competitors Tharimmune Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSTO) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSTO Stock Alerts